Genetic Mutations and Family History
693 articles
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
Families Working Together Against Pancreatic Cancer
Rob Greenstein discusses how Let’s Win helped his family after his sister Jackie was diagnosed with pancreatic cancer.
A New Vaccine for Advanced Pancreatic Cancer
An mRNA vaccine that works against KRAS mutations is being tested with and without immunotherapy for advanced or metastatic pancreatic cancer.
Faith in My Survival
Harry Schlechte had a Whipple procedure for his pancreatic cancer, but he credits his faith for getting him through treatment.
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
Treatment Options
Treatment Options After you are diagnosed, your oncologist will discuss treatments. Learn more about the different types of chemotherapy, surgery, and radiation used to treat pancreatic cancer. Chemotherapy Most pancreatic cancer patients receive some type of chemotherapy, no matter what the stage of disease, to stop or slow the cancer from growing. Chemotherapy can cause […]
Molecular Sequencing Leads to Customized Treatment
When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.
I Made It
Long-term survivor Carolynn Kiel lost her mother and sister to pancreatic cancer, so she learned to stay vigilant,
Pancreatic Cancer Risk Factors and Screening
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program held a webinar on risk factors and screening.
In the Fight Against Pancreatic Cancer, Knowledge Is Power
Oncologist Allyson Ocean, M.D., introduces Let’s Win, an interactive website for pancreatic cancer patients to learn about new treatments.
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
What Is a Clinical Trial?
A clinical trial is a type of research study that tests new drugs or drug combinations, procedures, or medical devices in patients with specific diseases or conditions. The goal of a clinical trial is to determine if a potential new treatment is safe and effective. Treatments that are tested in clinical trials have already been […]
Trying Targeted Treatments Used for Other Cancers
Researchers are trying kinase inhibitors that are effective for breast cancer, colorectal cancer, and melanoma on pancreatic cancer.
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.